Actively Recruiting
Implementing Metabolomics Informed Diet on Inflammatory Bowel Disease Patients
Led by University of California, San Diego · Updated on 2024-04-02
90
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying how diet affects inflammatory bowel disease (IBD), focusing on how dietary changes may influence the severity of IBD symptoms. This study aims to better understand the impact of diet on inflammation and disease activity in patients with IBD, including those with Crohn's Disease. The University of California, San Diego is leading this research to explore these effects using biological samples and disease markers. Participants will follow a Mediterranean Diet for 42 days as the main intervention. During this period, the diet's influence on the patients’ health will be monitored through various tests, including blood and stool sample collections. These samples will undergo metabolomics and microbiome analysis to observe changes linked to the diet. The study will assess disease activity using markers such as C-reactive protein and fecal calprotectin. Throughout the study, patients will provide blood and stool samples before and after the diet intervention. Researchers will measure disease activity using the short Crohn's Disease Activity Index after 42 days on the diet. The study involves regular monitoring of inflammation markers to evaluate how the Mediterranean Diet affects the disease state. Participants will be followed for the duration of the 42-day diet period to observe these changes.
CONDITIONS
Brief Title
Effect of Mediterranean Diet in Inflammatory Bowel Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years old or older
- Meet classification criteria for inflammatory bowel disease
- Have mild to moderate Crohn's Disease with a Crohn's disease activity index between 150-450
- Fecal calprotectin greater than 250 within 1 month of enrollment
You will not qualify if you...
- Unable to provide informed consent
- History of or current drug abuse
- Pregnancy
- Started or changed dose of standard-of-care treatment within 12 weeks of screening
- Known allergy to any component of the proposed diet
- Significant other medical or psychiatric conditions or medications that may affect results
- Not on a stable dose of medications such as steroids between sample collections
- Currently taking antibiotics
- C difficile infection within 4 weeks of enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 42 days
Participants follow a Mediterranean Diet to manage their inflammatory bowel disease.
Visits as per dietary adherence monitoring
Trial Site Locations
Total: 1 location
1
University of California, San Diego
San Diego, California, United States, 92161
Actively Recruiting
Research Team
M
Monica Guma, M.D., PhD
M
Mehrnaz Aghili, M.D.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here